目的研究黄芩滴眼剂的制备方法。
Objective To study the preparation method of scutellaria eye drop.
羟苯乙酯在荧光素钠滴眼剂中的防腐良好。
Ethylparaben is a good antiseptic in fluorescein sodium eyedrop.
进口滴眼剂的说明书质量优于国产滴眼剂。
The quality of the imported EDS was superior to that of the domestic EDS.
目的测定复方阿昔洛韦滴眼剂中阿昔洛韦和盐酸环胞苷的含量。
OBJECTIVE To determine the content of acyclovir and cyclocytidine hydrochloride in compound acyclovir eye drops.
结论：复方中药金芪滴眼剂对兔角膜上皮细胞有较好的保护作用。
Conclusions: Eye drops of JINQI promote the proliferation of rabbit corneal epithelial cells effectively.
本发明属于医药技术领域，公开了阿奇霉素滴眼剂及其制备方法。
The invention belongs to the technical field of medicine, and discloses azithromycin eye drop and a preparation method thereof.
目的了解我院3年间滴眼剂的使用情况，探讨我院滴眼剂的应用结构及趋势。
AIM to find out the use situation of the eye drops in our hospital during 3 yeas and to explore the use composition and tendency of them.
方法：采用紫外分光光度法测定诺氟沙星滴眼剂含量，采用初匀速法预测其有效期。
METHODS:Norfloxacin was determined by UV spectrophotometry, prediction of expiry by initial average rate methods.
目的：观察复方中药金芪滴眼剂对兔角膜上皮细胞及兔角膜基质层细胞增殖的影响。
Objective: To observe the impacts of JINQI, a kind of compound of Chinese herbs, on the growth of rabbit corneal epithelial cells and corneal stroma cells in vitro.
将其制成滴眼剂，治疗病毒性和细菌性角膜炎及急性结膜炎229例，取得较好效果。
Eye drops from the herb have been made and put into clinical use to treat 229 patients with viral and bacterial keratitis and acute conjunctivitis.
本文根据抗生素生物检定法测定氯霉素滴眼剂在不同贮存条件下放置半年稳定性的变化。
According to biological assay of antibiotics, we determined the change of stability of laid up for half a year under different storage conditions.
结论：纳他霉素滴眼剂可降低真菌性角膜炎兔眼溃疡评分、提高治愈率、有效预防并发症。
Conclusion: Natamycin treatment was found to be effective in fungal keratitis, which reduced the score of fungal keratitis in rabbits, and improved the cure rate and prevented complications.
近年来国内外研制成缓释、控释制剂的主要有片剂、胶囊剂、微球剂、滴眼剂、注射植入剂等。
In recent years, many sustained-released and controlled-release agents have been prepared successfully internal and abroad, such as tablets, capsule, micro spheres, eye drops, injection implant etc.
一种治疗近视的滴眼剂，属眼科用配制品领域。主要由下列重量配比的药物的水溶液混配而成。
Myopia treating eye drop as one kind of eye disease treating compound is compounded by mixing medicines and water solvent.
目的：制备氯霉素凝胶滴眼剂并建立其含量测定方法。方法：以卡波姆-940为基质制备凝胶；
OBJECTIVE: To prepare chloramphenicol eye was prepared with carbomer- 940 as base, and the content of proach.
目的：观察盐酸洛美沙星滴眼剂对金黄色葡萄球菌和铜绿假单胞杆菌所致家兔细菌性角膜炎的疗效。
Objective: To observe the therapeutic effect of lomefloxacin hydrochloride ophthalmic solution for the bacterial keratitis infected by Staphy.
方法：通过对不同原理制备原位胶化缓释滴眼剂的方法介绍，对影响滴眼剂胶化过程及稳定性的因素进行比较分析。
Methods: the factors affecting gel forming process and stability of eye drops are analyzed by introduction of the preparing methods of in situ gelling eye drops with different mechanisms.
与之前已批准的0.03%滴眼剂相同，贝美前列素0.01%滴眼液的给药方法为每晚1次，每次在眼压升高的眼睛内滴1滴。
As with the previously approved 0.03% formulation, bimatoprost 0.01% solution is administered as 1 drop in the affected eye once daily in the evening.
Similasan滴眼剂不含化学成分不会产生依赖性或反弹，使用本款或是其它的Similasan产品相当安全，不计年龄或身体状况。
Similasan Eye Drops contain no harsh chemicals and will not cause reliance or rebound. Use this and other Similasan products with confidence in their safety, no matter what your age or health status.
本发明属药物制剂领域，涉及一种含稳定剂的哌仑西平的外用滴眼制剂。
The invention belong to medicine preparation field, relating to a externally used eye drops containing stabilizing agent for piperilunxiping.
本发明属药物制剂领域，涉及一种含稳定剂的哌仑西平的外用滴眼制剂。
The invention belong to medicine preparation field, relating to a externally used eye drops containing stabilizing agent for piperilunxiping.
应用推荐